Patents by Inventor Karl Steven LaForge

Karl Steven LaForge has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7071315
    Abstract: Provided herein are variant alleles of a gene encoding a mu opioid receptor, along with cloning vectors for replicating such variant alleles, expressing vectors for expressing the variant alleles to produce variant mu opioid receptors, and antibodies to such variant receptors. Also disclosed are binding characteristics of such variant receptors regarding binding to opioid ligands, and the using of such binding characteristics to diagnose a subjects susceptibility to pain, susceptibility to an addictive disease, selecting an appropriate pain reliever along with a therapeutically effective amount of the reliever to administer to a subject suffering from pain. In addition, diagnostic methods for diagnosing a disease or disorder such as infertility, constipation, diarrhea, decreased immune response relative to a standard, and decreased ability to withstand stress relative to a standard, along with commercial kits for diagnosing such diseases or disorders.
    Type: Grant
    Filed: June 18, 2001
    Date of Patent: July 4, 2006
    Assignee: The Rockefeller University
    Inventors: Mary Jeanne Kreek, Karl Steven LaForge
  • Patent number: 7033759
    Abstract: Provided herein are variant alleles of a gene encoding a kappa opioid receptor, along with cloning vectors for replicating such variant alleles, and expressing vectors for expressing the variant alleles to produce variant kappa opioid receptors.
    Type: Grant
    Filed: July 13, 2001
    Date of Patent: April 25, 2006
    Assignee: The Rockfeller University
    Inventors: Mary Jeanne Kreek, Vadim Yuferov, Karl Steven LaForge
  • Publication number: 20040209250
    Abstract: Provided herein are variant alleles of a gene encoding a mu opioid receptor, along with cloning vectors for replicating such variant alleles, expressing vectors for expressing the variant alleles to produce variant mu opioid receptors, and antibodies to such variant receptors. Also disclosed are binding characteristics of such variant receptors regarding binding to opioid ligands, and the using of such binding characteristics to diagnose a subjects susceptibility to pain, susceptibility to an addictive disease, selecting an appropriate pain reliever along with a therapeutically effective amount of the reliever to administer to a subject suffering from pain. In addition, diagnostic methods for diagnosing a disease or disorder such as infertility, constipation, diarrhea, decreased immune response relative to a standard, and decreased ability to withstand stress relative to a standard, along with commercial kits for diagnosing such diseases or disorders.
    Type: Application
    Filed: June 18, 2001
    Publication date: October 21, 2004
    Inventors: Mary Jeanne Kreek, Karl Steven LaForge
  • Publication number: 20040097704
    Abstract: Provided herein are variant alleles of a gene encoding a kappa opioid receptor, along with cloning vectors for replicating such variant alleles, and expressing vectors for expressing the variant alleles to produce variant kappa opioid receptors.
    Type: Application
    Filed: July 13, 2001
    Publication date: May 20, 2004
    Inventors: Mary Jeanne Kreek, Vadim Yuferov, Karl Steven LaForge
  • Publication number: 20030008289
    Abstract: Provided herein are variant alleles of a gene encoding a orphanin FQ/nociceptin receptor, along with cloning vectors for replicating such variant alleles, and expressing vectors for expressing the variant alleles to produce variant orphanin FQ/nociceptin receptors.
    Type: Application
    Filed: October 9, 2001
    Publication date: January 9, 2003
    Inventors: Mary Jeanne Kreek, Karl Steven LaForge
  • Publication number: 20020142312
    Abstract: Provided herein is a variant allele of a gene encoding a serotonin 1B receptor, A−161T, along with cloning vectors for replicating such variant alleles, and expressing vectors for expressing the variant alleles to identify alterations in the expression of serotonin 1B receptors, for identifying individuals predisposed to addictive, neurologic or psychiatric diseases.
    Type: Application
    Filed: May 15, 2001
    Publication date: October 3, 2002
    Inventors: Tessa Cigler, Karl Steven LaForge, Mary Jeanne Kreek
  • Patent number: 6337207
    Abstract: Provided herein are variant alleles of a gene encoding a mu opioid receptor, along with cloning vectors for replicating such variant alleles, expressing vectors for expressing the variant alleles to produce variant mu opioid receptors, and antibodies to such variant receptors. Also disclosed are binding characteristics of such variant receptors regarding binding to opioid ligands, and the using of such binding characteristics to diagnose a subjects susceptibility to pain, susceptibility to an addictive disease, selecting an appropriate pain reliever along with a therapeutically effective amount of the reliever to administer to a subject suffering from pain. In addition, diagnostic methods for diagnosing a disease or disorder such as infertility, constipation, diarrhea, decreased immune response relative to a standard, and decreased ability to withstand stress relative to a standard, along with commercial kits for diagnosing such diseases or disorders.
    Type: Grant
    Filed: July 10, 1998
    Date of Patent: January 8, 2002
    Assignees: The Rockefeller University, The Advanced Research and Technology Institute, Inc.
    Inventors: Mary Jeanne Kreek, Karl Steven LaForge, Lei Yu, Jay A. Tischfield
  • Patent number: 6335168
    Abstract: Provided herein are variant alleles of a gene encoding a mu opioid receptor, along with cloning vectors for replicating such variant alleles, expressing vectors for expressing the variant alleles to produce variant mu opioid receptors, and antibodies to such variant receptors. Also disclosed are binding characteristics of such variant receptors regarding binding to opioid ligands, and the using of such binding characteristics to diagnose a subjects susceptibility to pain, susceptibility to an addictive disease, selecting an appropriate pain reliever along with a therapeutically effective amount of the reliever to administer to a subject suffering from pain. In addition, diagnostic methods for diagnosing a disease or disorder such as infertility, constipation, diarrhea, decreased immune response relative to a standard, and decreased ability to withstand stress relative to a standard, along with commercial kits for diagnosing such diseases or disorders.
    Type: Grant
    Filed: July 9, 1999
    Date of Patent: January 1, 2002
    Assignees: The Rockefeller University, The Advanced Research and Technology Institute, Inc.
    Inventors: Mary Jeanne Kreek, Karl Steven LaForge, Lei Yu, Jay A. Tischfield
  • Publication number: 20010053849
    Abstract: The present invention relates to the high throughput analysis of polymorphisms of a family of genes associated with addiction and alcohol dependence. Included are probes prepared by a variety of techniques, a sample plate that may utilize DNA chip-type technology. The invention is adapted to identify both physiological and genetic conditions of subjects so tested, and should provide a rapid and inexpensive means for accomplishing the same.
    Type: Application
    Filed: June 16, 1999
    Publication date: December 20, 2001
    Inventors: MARY JEANNE KREEK, KARL STEVEN LAFORGE, RUDOLPH SPANGLER